You're reading the free version. Trader adds the live tape and alerts.
Start tracking
ONC Exercise Disclosure
Oyler John · SEC Form 4 · Filed Jul 17, 2026
Exercise
Calculated transaction value
$0
Oyler John Chief Executive Officer
ONC
Transaction date
Jul 17, 2026
Public filing date
Jul 17, 2026
Filing lag
Filed same day
ONC daily price context
Close on/before transaction
$312.02
Jul 17, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Share Option (Right to Buy) on Ordinary Shares
- Quantity / price
- 840,164 shares @ $0
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001042047-26-000015
Filing cohort
Transactions in this filing
Showing 11 of 11
Trades
11
Issuers
1
Estimated value
$27.92M
Buys / sales
0 / 9
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Beone Medicines Ltd. ONC | Exercise | Jul 17, 2026 | $7.75M |
| Beone Medicines Ltd. ONC | Sale | Jul 17, 2026 | $439.49K |
| Beone Medicines Ltd. ONC | Sale | Jul 17, 2026 | $183.26K |
| Beone Medicines Ltd. ONC | Sale | Jul 17, 2026 | $210.16K |
| Beone Medicines Ltd. ONC | Sale | Jul 17, 2026 | $1.5M |
| Beone Medicines Ltd. ONC | Sale | Jul 17, 2026 | $1.73M |
| Beone Medicines Ltd. ONC | Sale | Jul 17, 2026 | $11.18M |
| Beone Medicines Ltd. ONC | Sale | Jul 17, 2026 | $4.67M |
| Beone Medicines Ltd. ONC | Sale | Jul 17, 2026 | $232.6K |
| Beone Medicines Ltd. ONC | Sale | Jul 17, 2026 | $16.07K |
| Beone Medicines Ltd. ONC Current | Exercise | Jul 17, 2026 | $0 |